Pharmacyclics cancer drug successful as combination therapy: independent panel

March 16, 2015 9:17 PM

13 0

REUTERS: An independent panel recommended unblinding a late-stage study testing Pharmacyclics Inc and Johnson & Johnson's Imbruvica, after the treatment was successful against two similar forms of cancer in combination with other drugs.

Pharmacyclics, which recently agreed to be acquired by AbbVie Inc for about US$21 billion, said Imbruvica showed a statistically significant improvement in survival without disease progression, the study's main goal.

Read more

To category page